GB201900554D0 - Mesodermal killer (mk) cell - Google Patents

Mesodermal killer (mk) cell

Info

Publication number
GB201900554D0
GB201900554D0 GBGB1900554.5A GB201900554A GB201900554D0 GB 201900554 D0 GB201900554 D0 GB 201900554D0 GB 201900554 A GB201900554 A GB 201900554A GB 201900554 D0 GB201900554 D0 GB 201900554D0
Authority
GB
United Kingdom
Prior art keywords
mesodermal
killer
cell
mesodermal killer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1900554.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Therapy Ltd
Original Assignee
Cell Therapy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapy Ltd filed Critical Cell Therapy Ltd
Priority to GBGB1900554.5A priority Critical patent/GB201900554D0/en
Publication of GB201900554D0 publication Critical patent/GB201900554D0/en
Priority to US17/310,064 priority patent/US20230047325A1/en
Priority to PCT/GB2020/050060 priority patent/WO2020148520A1/en
Priority to CN202080021356.7A priority patent/CN113574166A/en
Priority to JP2021541188A priority patent/JP2022517400A/en
Priority to CA3126744A priority patent/CA3126744A1/en
Priority to EP20700533.1A priority patent/EP3911733A1/en
Priority to AU2020209441A priority patent/AU2020209441A1/en
Ceased legal-status Critical Current

Links

GBGB1900554.5A 2019-01-15 2019-01-15 Mesodermal killer (mk) cell Ceased GB201900554D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1900554.5A GB201900554D0 (en) 2019-01-15 2019-01-15 Mesodermal killer (mk) cell
US17/310,064 US20230047325A1 (en) 2019-01-15 2020-01-13 Mesodermal killer (mk) cell
PCT/GB2020/050060 WO2020148520A1 (en) 2019-01-15 2020-01-13 Mesodermal killer (mk) cell
CN202080021356.7A CN113574166A (en) 2019-01-15 2020-01-13 Mesoderm Killing (MK) cells
JP2021541188A JP2022517400A (en) 2019-01-15 2020-01-13 Mesoderm killer (MK) cells
CA3126744A CA3126744A1 (en) 2019-01-15 2020-01-13 Mesodermal killer (mk) cell
EP20700533.1A EP3911733A1 (en) 2019-01-15 2020-01-13 Mesodermal killer (mk) cell
AU2020209441A AU2020209441A1 (en) 2019-01-15 2020-01-13 Mesodermal killer (MK) cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1900554.5A GB201900554D0 (en) 2019-01-15 2019-01-15 Mesodermal killer (mk) cell

Publications (1)

Publication Number Publication Date
GB201900554D0 true GB201900554D0 (en) 2019-03-06

Family

ID=65528196

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1900554.5A Ceased GB201900554D0 (en) 2019-01-15 2019-01-15 Mesodermal killer (mk) cell

Country Status (1)

Country Link
GB (1) GB201900554D0 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198357A (en) 1988-04-26 1993-03-30 Ellco Food Ab Preparation of a blood platelet lysate for use in a cell culture medium for hybridoma cells
WO2013005053A2 (en) 2011-07-06 2013-01-10 Cell Therapy Limited Progenitor cells of mesodermal lineage
WO2013076507A2 (en) 2011-11-23 2013-05-30 Cell Therapy Limited Platelet lysate gel
WO2015189587A1 (en) 2014-06-12 2015-12-17 Cell Therapy Limited Immuno-modulatory progenitor (imp) cell
WO2015189586A1 (en) 2014-06-12 2015-12-17 Cell Therapy Limited Hybrid composition
WO2017025729A1 (en) 2015-08-07 2017-02-16 Cell Therapy Limited Immuno-oncology mesodermal progenitor (iomp) cell

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198357A (en) 1988-04-26 1993-03-30 Ellco Food Ab Preparation of a blood platelet lysate for use in a cell culture medium for hybridoma cells
WO2013005053A2 (en) 2011-07-06 2013-01-10 Cell Therapy Limited Progenitor cells of mesodermal lineage
WO2013076507A2 (en) 2011-11-23 2013-05-30 Cell Therapy Limited Platelet lysate gel
WO2015189587A1 (en) 2014-06-12 2015-12-17 Cell Therapy Limited Immuno-modulatory progenitor (imp) cell
WO2015189586A1 (en) 2014-06-12 2015-12-17 Cell Therapy Limited Hybrid composition
WO2017025729A1 (en) 2015-08-07 2017-02-16 Cell Therapy Limited Immuno-oncology mesodermal progenitor (iomp) cell

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", MACK PUBLISHING COMPANY
ADCC; WEI HSEUN YEAP ET AL., SCIENTIFIC REPORTS, vol. 6, 2016
AKBARZADEH ET AL., NANOSCALE RESEARCH LETTERS, vol. 8, 2013, pages 102
ANASTASIADIS ET AL., J CARDIOVASC TRANSL RES., vol. 9, no. 3, June 2016 (2016-06-01), pages 202 - 13
BRUNETTA, E. ET AL., BLOOD, vol. 114, 2009, pages 3822 - 3830
CHAN ET AL., J IMMUNOL, vol. 184, no. 2, 15 January 2010 (2010-01-15), pages 902 - 911
DEUSS ET AL., J BIOL CHEM., vol. 292, no. 27, 7 July 2017 (2017-07-07), pages 11413 - 11422
FUCHS ET AL., J IMMUNOL, vol. 172, no. 7, 1 April 2004 (2004-04-01), pages 3994 - 3998
GONG; JH; MAKI; G; KLINGEMANN; HG: "Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells", LEUKAEMIA, vol. 8, no. 4, 1994, pages 658 - 658, XP002914219
HUMPHRIES, METHODS MOL BIOL., vol. 522, 2009, pages 203 - 10
MEGHANA ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES, vol. 1, no. 1, 2012, pages 1 - 10
MESSAL ET AL., EUR J IMMUNOL., vol. 41, no. 12, December 2011 (2011-12-01), pages 3443 - 54
MULLER; LUSCINSKAS, METHODS ENZYMOL., vol. 443, 2008, pages 155 - 176
SIRSI; BORDEN, BUBBLE SCI ENG TECHNOL., vol. 1, no. 1-2, November 2009 (2009-11-01), pages 3 - 17
WENDEL ET AL., CANCER RES., vol. 68, no. 20, 15 October 2008 (2008-10-15), pages 8437 - 45
YAGITA; M; HUANG; CL; UMEHARA; H; MATSUO; Y; TABATA; R; MIYAKE; M; KONATA; Y; TAKATSUKI; K: "A novel natural killer cell line (KHYG-1) from a subject with aggressive natural killer cell leukemia carrying a p53 point mutation", LEUKAEMIA, vol. 14, no. 5, 2000, pages 922 - 930, XP055510744, DOI: doi:10.1038/sj.leu.2401769
ZAMAI ET AL., J EXP MED., vol. 188, no. 12, 21 December 1998 (1998-12-21), pages 2375 - 2380
ZHANG ET AL., J IMMUNOTHER, vol. 34, no. 2, March 2011 (2011-03-01), pages 187 - 195

Similar Documents

Publication Publication Date Title
IL288077A (en) Solid state forms
CA186861S (en) Camera
CA193496S (en) Screwdriver
GB201803079D0 (en) Cell
EP3874683C0 (en) Network-charging communication-failure handling
EP3814013A4 (en) Thermal block
SG10201905980VA (en) Multiple chamber innerduct structure
GB201904887D0 (en) Lifebit al
GB201819540D0 (en) T cell modification
IL292873A (en) Spatio-temporal-interactive networks
GB201904971D0 (en) Cell
EP3581131B8 (en) Trochanter plates
FI3899996T3 (en) Electrolyte compositions
GB201906202D0 (en) Cell
IL287256A (en) Relationship discovery
GB201916842D0 (en) Mesodermal killer (mk) cell
GB201900554D0 (en) Mesodermal killer (mk) cell
EP4048783C0 (en) Modified cell
GB201816658D0 (en) Mesodermal killer (MK) cell
GB201910873D0 (en) Novel uses
GB201902453D0 (en) Destination prediciton
GB201805918D0 (en) Cell
GB2572073B (en) Low loss header
CA195219S (en) Overall
GB201910252D0 (en) Spanner

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)